MLchartDataset catalogue

glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine

Term · Oncology and biomedicine · MLC-T-ONC-013961

A cancer vaccine comprised of autologous dendritic cells pulsed with synthetic glioma-associated antigen (GAA) peptides with potential antineoplastic activity. Upon administration, this vaccine may stimulate anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against GAA peptide-expressing glioma cells, resulting in tumor cell lysis.

Table 1. Record
IdentifierMLC-T-ONC-013961
FieldOncology and biomedicine
AbbreviationGAA peptide-pulsed autologous dendritic cell vaccine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013961",
  "term": "glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A cancer vaccine comprised of autologous dendritic cells pulsed with synthetic glioma-associated antigen (GAA) peptides with potential antineoplastic activity. Upon administration, this vaccine may stimulate anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against GAA peptide-expressing glioma cells, resulting in tumor cell lysis.",
  "abbreviation": "GAA peptide-pulsed autologous dendritic cell vaccine",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/glioma-associated-antigen-peptide-pulsed-autologous-dendritic-cell-vaccine/"
}

Record 8,022 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.